{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:19:35Z","timestamp":1767986375832,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.clinthera.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T09:27:14Z","timestamp":1266485234000},"page":"1-10","source":"Crossref","is-referenced-by-count":24,"title":["Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: A meta-analysis of controlled clinical trials"],"prefix":"10.1016","volume":"32","author":[{"given":"Seyed-Moayed","family":"Alavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Vahid","family":"Tabatabaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/j.ajkd.2003.12.030","article-title":"Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: Causes and consequences","volume":"43","author":"Espinosa","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.clinthera.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1067\/mic.2003.55","article-title":"Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east","volume":"31","author":"Saxena","year":"2003","journal-title":"Am J Infect Control."},{"key":"10.1016\/j.clinthera.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000093252","article-title":"Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis","volume":"104","author":"Gallego","year":"2006","journal-title":"Nephron Clin Pract."},{"key":"10.1016\/j.clinthera.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000076951","article-title":"The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit","volume":"13","author":"Saxena","year":"2004","journal-title":"Med Princ Pract."},{"key":"10.1016\/j.clinthera.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0272-6386(05)80017-4","article-title":"Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis","volume":"37","author":"Petrosillo","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.clinthera.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000013565","article-title":"Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients","volume":"20","author":"Alfurayh","year":"2000","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1542-4758.2008.00284.x","article-title":"Hepatitis B and C in dialysis units in Iran: Changing the epidemiology","volume":"12","author":"Alavian","year":"2008","journal-title":"Hemodial Int."},{"key":"10.1016\/j.clinthera.2010.01.005_bib8","first-page":"245","article-title":"Hepatitis C among hemodialysis patients: Impact of strict adherence to universal precautions","volume":"7","author":"Nemati","year":"2007","journal-title":"Hepatitis Monthly."},{"key":"10.1016\/j.clinthera.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/039139880202500303","article-title":"Novel perspectives on hepatitis B vaccine in dialysis population","volume":"25","author":"Fabrizi","year":"2002","journal-title":"Int J Artif Organs."},{"key":"10.1016\/j.clinthera.2010.01.005_bib10","first-page":"25","article-title":"HBV vaccination in chronic renal failure patients","volume":"6","author":"Sali","year":"2006","journal-title":"Hepatitis Monthly."},{"key":"10.1016\/j.clinthera.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0272-6386(99)70312-4","article-title":"Protective effect of hepatitis B vaccine in chronic hemodialysis patients","volume":"33","author":"Miller","year":"1999","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.clinthera.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000183270","article-title":"Immunologic abnormalities in hemodialysis patients: Improvement after pyridoxine therapy","volume":"38","author":"Casciato","year":"1984","journal-title":"Nephron."},{"key":"10.1016\/j.clinthera.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.1986.129","article-title":"Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defect","volume":"29","author":"Kurz","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.clinthera.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.ndt.a027346","article-title":"Influence of uraemia and haemodialysis on host defence and infection","volume":"11","author":"Vanholder","year":"1996","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.clinthera.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/j.ajkd.2003.08.019","article-title":"Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: Earlier is better","volume":"42","author":"DaRoza","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.clinthera.2010.01.005_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139x.2000.00029.x","article-title":"Vaccine recommendations for patients on chronic dialysis","volume":"13","author":"Rangel","year":"2000","journal-title":"Semin Dial."},{"key":"10.1016\/j.clinthera.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/039139880102401003","article-title":"Hepatitis B vaccine and dialysis: Current issues","volume":"24","author":"Fabrizi","year":"2001","journal-title":"Int J Artif Organs."},{"key":"10.1016\/j.clinthera.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2006.03002.x","article-title":"Meta-analysis: Intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ndt\/12.6.1204","article-title":"Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation","volume":"12","author":"Fabrizi","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1016\/j.vaccine.2009.07.014","article-title":"Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial","volume":"27","author":"Miquilena-Colina","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.clinthera.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2006.03035.x","article-title":"Meta-analysis: The adjuvant role of granulocyte macrophagecolony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.01.005_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1365-2036.2006.02923.x","article-title":"Meta-analysis: The adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in endstage renal disease","volume":"23","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.01.005_bib23","first-page":"3184","article-title":"Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients\u2014a pilot study","volume":"46","author":"Krastev","year":"1999","journal-title":"Hepatogastroenterology."},{"key":"10.1016\/j.clinthera.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1440-1797.2008.00952.x","article-title":"Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients","volume":"13","author":"Sali","year":"2008","journal-title":"Nephrology (Carlton)."},{"key":"10.1016\/j.clinthera.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-8518-4-3","article-title":"Levamizole enhances immune responsiveness to intra-dermal and intramuscular hepatitis B vaccination in chronic hemodialysis patients","volume":"4","author":"Argani","year":"2006","journal-title":"J Immune Based Ther Vaccines."},{"key":"10.1016\/j.clinthera.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1525-1594.2002.06928.x","article-title":"Levamisole treatment enhances protective antibody re sponse to hepatitis B vaccination in hemodialysis patients","volume":"26","author":"Kayatas","year":"2002","journal-title":"Artif Organs."},{"key":"10.1016\/j.clinthera.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000045598","article-title":"Effect of oral levamisole supplementation to hepatitis B vaccination on the rate of immune response in chronic hemodialysis patients","volume":"84","author":"Deniz Ayli","year":"2000","journal-title":"Nephron."},{"key":"10.1016\/j.clinthera.2010.01.005_bib28","series-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.clinthera.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics."},{"key":"10.1016\/j.clinthera.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"key":"10.1016\/j.clinthera.2010.01.005_bib31","first-page":"188","article-title":"Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children","volume":"16","author":"Demirci","year":"2005","journal-title":"Turk J Gastroenterol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib32","first-page":"284","article-title":"Therapeutic effect of levamisole plus HBV vaccine and dipyridamole on patients chronically infected by HBV with precore mutation [in Chinese]","volume":"18","author":"Luo","year":"2004","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi."},{"key":"10.1016\/j.clinthera.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1749-6632.1993.tb35874.x","article-title":"Experimental modulation of IL-1 production and cell surface molecule expression by levamisole","volume":"685","author":"Kimball","year":"1993","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.clinthera.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1008099612354","article-title":"Levamisole and interleukin-2 for advanced malignancy","volume":"11","author":"Holcombe","year":"1998","journal-title":"Biotherapy."},{"key":"10.1016\/j.clinthera.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2567.2000.00042.x","article-title":"Levamisole induces interleukin-18 and shifts type 1\/type 2 cytokine balance","volume":"100","author":"Szeto","year":"2000","journal-title":"Immunology."},{"key":"10.1016\/j.clinthera.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1091-255X(01)80048-2","article-title":"Toxicity and effects of adjuvant therapy in colon cancer: Results of the German prospective, controlled randomized multicenter trial FOGT-1","volume":"5","author":"Staib","year":"2001","journal-title":"J Gastrointest Surg."},{"key":"10.1016\/j.clinthera.2010.01.005_bib37","first-page":"183","article-title":"Investigating the role of immunomodulation for colon cancer prevention: Results of an in vivo dose escalation trial of levamisole with immunologic endpoints","volume":"25","author":"Holcombe","year":"2001","journal-title":"Cancer Detect Prev."},{"key":"10.1016\/j.clinthera.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002620050337","article-title":"Levamisole regulates the proliferation of murine liver T cells through Kupffer-cell-derived cytokines","volume":"43","author":"Johnkoski","year":"1996","journal-title":"Cancer Immunol Immunother."},{"key":"10.1016\/j.clinthera.2010.01.005_bib39","first-page":"349","article-title":"Immunotherapy of leprosy","volume":"68","author":"Katoch","year":"1996","journal-title":"Indian J Lepr."},{"key":"10.1016\/j.clinthera.2010.01.005_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/08923979409019745","article-title":"Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value","volume":"16","author":"Printzis","year":"1994","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hep.1840160503","article-title":"Therapy for chronic hepatitis B with lymphoblastoid interferonalpha and levamisole","volume":"16","author":"Fattovich","year":"1992","journal-title":"Hepatology."},{"key":"10.1016\/j.clinthera.2010.01.005_bib42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(05)80555-0","article-title":"Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole","volume":"19","author":"Bosch","year":"1993","journal-title":"J Hepatol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.1840180207","article-title":"Levamisole and interferon in children with chronic hepatitis B","volume":"18","author":"Ruiz-Moreno","year":"1993","journal-title":"Hepatology."},{"key":"10.1016\/j.clinthera.2010.01.005_bib44","first-page":"175","article-title":"Results of combined therapy using levamisole for patients with influenza complicated by pneumonia [in Russian]","volume":"29","author":"Grishchenko","year":"1984","journal-title":"Vopr Virusol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1200\/JCO.1993.11.1.125","article-title":"Dose-related immunologic effects of levamisole in patients with cancer","volume":"11","author":"Janik","year":"1993","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1040-8428(02)00014-8","article-title":"Adjuvant therapy of malignant melanoma","volume":"44","author":"Molife","year":"2002","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1479-666X(05)80086-1","article-title":"Adjuvant therapies in the treatment of stage II and III malignant melanoma","volume":"3","author":"Kavanagh","year":"2005","journal-title":"Surgeon."},{"key":"10.1016\/j.clinthera.2010.01.005_bib48","first-page":"2271","article-title":"Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU","volume":"15","author":"De Brabander","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.clinthera.2010.01.005_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1023\/A:1019510628249","article-title":"Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma","volume":"33","author":"Aksoy","year":"2001","journal-title":"Int Urol Nephrol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.sla.0000171033.65639.a9","article-title":"Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: Results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha","volume":"242","author":"Link","year":"2005","journal-title":"Ann Surg."},{"key":"10.1016\/j.clinthera.2010.01.005_bib51","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cdp.2005.08.002","article-title":"Immunomodulation with low dose levamisole in patients with colonic polyps","volume":"30","author":"Holcombe","year":"2006","journal-title":"Cancer Detect Prev."},{"key":"10.1016\/j.clinthera.2010.01.005_bib52","first-page":"1","article-title":"Present status","volume":"46","author":"Rizzetto","year":"2000","journal-title":"Minerva Gastroenterol Dietol."},{"key":"10.1016\/j.clinthera.2010.01.005_bib53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/sj.bjc.6602555","article-title":"A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer","volume":"92","author":"Schippinger","year":"2005","journal-title":"Br J Cancer."},{"key":"10.1016\/j.clinthera.2010.01.005_bib54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.clinthera.2010.01.005_bib55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.156.6.661","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.clinthera.2010.01.005_bib56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1742-1241.2007.01470.x","article-title":"Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients","volume":"63","author":"Ramezani","year":"2009","journal-title":"Int J Clin Pract."},{"key":"10.1016\/j.clinthera.2010.01.005_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5414\/CNP68228","article-title":"Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination","volume":"68","author":"Tsouchnikas","year":"2007","journal-title":"Clin Nephrol."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T01:21:23Z","timestamp":1558833683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0149291810000068"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.01.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}